Skip to main content
Clinical Trials/NCT03279419
NCT03279419
Completed
Not Applicable

Thermal Imaging of the Peripheral Vasculature in Liver Disease.

University of Edinburgh1 site in 1 country66 target enrollmentSeptember 1, 2019
ConditionsLiver Diseases

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Liver Diseases
Sponsor
University of Edinburgh
Enrollment
66
Locations
1
Primary Endpoint
Changes in peripheral vasculature as assessed by thermal imaging
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a feasibility study, to assess if thermal imaging and/or near infrared imaging will be useful in identifying changes in the peripheral circulation in patients with different stages of liver disease.

The aim of this study is to use new and advanced thermal imaging techniques to identify changes in the peripheral circulation and hand temperature in patients with liver disease. These changes could be used as a non-invasive marker of the severity and progression of liver disease. Thermal imaging will also be used to assess the changes in the peripheral vasculature with the use of terlipressin, a drug used as treatment for specific complications of liver disease.

Patients with acute or chronic liver disease from any aetiology will be recruited, along with patients without liver disease as healthy controls. Patients with disease or on drugs known to affect the peripheral vasculature will be excluded.

All studies will be performed in a ward setting in the Royal Infirmary of Edinburgh. The subjects will be required for up to three sessions, each lasting 30 minutes. The session will involve static thermal images being taken, and video images of the hands warming up after being cooled for 30 seconds in water at a temperature of 7 degrees Celsius. If the patient is receiving terlipressin therapy, static images will be taken before, during and after terlipressin therapy.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
December 1, 2019
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosis of chronic liver disease (any stage)
  • diagnosis of acute liver disease (any aetiology)

Exclusion Criteria

  • on drugs known to affect peripheral circulation
  • conditions known to affect peripheral circulation e.g. Raynauds

Outcomes

Primary Outcomes

Changes in peripheral vasculature as assessed by thermal imaging

Time Frame: 2 years

Secondary Outcomes

  • Changes in peripheral vasculature in response to terlipressin therapy.(2 years)

Study Sites (1)

Loading locations...

Similar Trials